Top ten antipsychotic drugs in the U.S. by revenue 2011-2012

Published by Statista Research Department, Aug 1, 2012
This statistic represents the top antipsychotic drugs in the United States, based on revenue between July 2011 and June 2012. In this period, antipsychotic drug Abilify generated some 5.4 billion U.S. dollars of revenues.

Top antipsychotic drugs in the United States based on revenue in 2011-2012 (in million U.S. dollars)

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

August 2012

Region

United States

Survey time period

July 2011 to June 2012

Open this statistic in...
Spanish
Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$149 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

6

Other regions

10

Related statistics

8

Further related statistics

9

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical market in ThailandDemographics of ThailandHealth in ThailandMedical device industry in ThailandCoronavirus (COVID-19) pandemic in Thailand
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu